Increased levels of talin1, integrins α5-8, α10, α11, αV, β3-5, and leukocyte-specific integrins α4 and αE show correlation with either high increased or high decreased HR in various cancers, making them potential candidates for treatment prognosis markers and therapy targets. This evidence concerns the gene TLN1 and cancer.